Posts Tagged ‘life sciences consulting’



Welcoming Head of Digital Health Strategy Paul Sonnier as Newest Team Member

March 13th, 2012
Posted by

I’m delighted to announce that Paul Sonnier, formerly a strategic advisor to Popper and Company, has joined our core team as Head of Digital Health Strategy.
 
Our core team provides diversity and expertise to resolve problems and create strategies in the health arena for our life science clients. Paul, who has recently been described as a catalyst in the wireless and mobile health field, brings his familiarity, insights and experience to our existing team of experts whose operational backgrounds span clinical, technology, marketing and finance in a variety of capacities in the diagnostics, medical device and pharmaceutical industries.
  Read the rest of this entry »

Tags: , , , , , ,
Posted in Our News | 2 Comments »





On Patenting Genes and Their Correlations: It’s a Chicken-Egg Problem

August 26th, 2011
Posted by

Last month, my colleague Shane Climie wrote a post inspired by an article in the New York Times (“How Bright Promise in Cancer Testing Fell Apart”), which exposed disturbing and cautionary insights into the application of genetic testing technology. Today, I’m responding to a recent New York Times article in which reporter Andrew Pollack wrote of challenges facing Myriad Genetics in spite of the company having received a victory when a federal appeals court upheld the company’s patents on two human genes ­– and the validity of gene patents.
 
It’s worth checking out Andy’s article for more context, but here are my two cents on some of the issues covered:

     

  • My hunch is that eventually courts will rule (and in so doing give clear guidance) that while products of nature cannot be patented, companies likely will be able to continue to patent the knowledge that a gene or other physiological marker (all of which are “products of nature”) correlates to a particular condition, disease, and/or drug response. This is a key point of clarity that is needed in order for the field of “personalized medicine” to reach its full potential. Read the rest of this entry »

Tags: , , , , ,
Posted in Our Views | No Comments »